| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.099 | 0.02 |